News
May 5, 2020

Challenges and opportunities for using AI to help people with disabilities

Videos from conference sponsored by Regenstrief, Harvard and Stanford now available online

Regenstrief Institute, Harvard University and Stanford School of Medicine hosted an online conference exploring the opportunities for leveraging artificial intelligence to improve the lives of people with disabilities and dependencies, and the entire discussion is now available for free online.

AI has potential for both positive and negative impacts on those with disabilities. Legal scholars, ethicists, AI developers, clinicians and people living with disabilities and dependencies discussed best practices and guidelines for stakeholders, articulating clear criteria for developers and medical providers who want to use AI technology to improve lives.

Regenstrief Vice President for Research Development Eneida Mendonca, M.D., PhD, helped to organize this conference. Dr. Mendonca also is a professor at Indiana University School of Medicine.

Regenstrief Researcher Noll Campbell, PharmD, participated in the conference’s panel on AI and disability. Dr. Campbell, also an assistant professor of pharmacy practice at Purdue University College of Pharmacy, is a geriatric pharmacotherapy expert. He spoke about how data used to create and train AI models may actually not help populations with certain disabilities, such as dementia, and in fact may actually cause unintended consequences.

The webinar was sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School; the Harvard Law School Project on Disability (HPOD); the Edmond J. Safra Center for Ethics at Harvard University; the Regenstrief Institute; and the Presence at the Stanford University School of Medicine. Support provided by the Oswald DeN. Cammann Fund at Harvard University.

Watch the entire conference here.

  • Harvard AI Conference

Related News

Paul Musey, MD, MSC

Peer-supported online therapy improves anxiety after emergency visits for low-risk chest pain

Randomized trial finds peer-supported online therapy improved anxiety after discharge for low-risk chest pain, with the largest difference among

Group photo showing all Regenstrief-affiliated participants in the 2026 AMIA Annual Symposium in Dallas, TX

Regenstrief highlighted AI and learning health systems research at AMIA 2026

Regenstrief Institute research scientists, fellows and affiliates shared work on artificial intelligence, health information exchange and public health informatics

photo of Dr. Josh Vest with New England Journal of Medicine logo

NEJM Perspective calls for screening tailored to older adults’ social needs

Regenstrief Institute and Weill Cornell Medicine researchers outline how health systems can identify unmet needs more accurately and connect

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney